FR88M - - Google Patents
Info
- Publication number
- FR88M FR88M FR834523A FR834523A FR88M FR 88 M FR88 M FR 88M FR 834523 A FR834523 A FR 834523A FR 834523 A FR834523 A FR 834523A FR 88 M FR88 M FR 88M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR834523A FR88M (ru) | 1960-07-29 | 1960-07-29 | |
| GB26856/61A GB922361A (en) | 1960-07-29 | 1961-07-25 | Improvements in and relating to lysine orotate and its therapeutic applications |
| CH884561A CH394216A (fr) | 1960-07-29 | 1961-07-27 | Procédé de préparation d'orotate de lysine |
| US127154A US3161565A (en) | 1960-07-29 | 1961-07-27 | Lysine orotate |
| BE606638A BE606638A (fr) | 1960-07-29 | 1961-07-27 | Orotate de lysine et ses applications thérapeutiques |
| ES0269442A ES269442A1 (es) | 1960-07-29 | 1961-07-28 | Procedimiento de preparaciën de orotato de lisina |
| DK312061AA DK105811C (da) | 1960-07-29 | 1961-07-28 | Fremgangsmåde til fremstilling af lysinorotat. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR834523A FR88M (ru) | 1960-07-29 | 1960-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR88M true FR88M (ru) | 1961-01-09 |
Family
ID=8736588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR834523A Active FR88M (ru) | 1960-07-29 | 1960-07-29 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3161565A (ru) |
| BE (1) | BE606638A (ru) |
| CH (1) | CH394216A (ru) |
| DK (1) | DK105811C (ru) |
| ES (1) | ES269442A1 (ru) |
| FR (1) | FR88M (ru) |
| GB (1) | GB922361A (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037488A2 (de) * | 1980-03-25 | 1981-10-14 | Hrvoje Dr. Krnjevic | Pharmazeutisches Mittel zur Heilung von entzündlichen und/oder degenerativen und/oder atrophischen Schleimhauterkrankungen |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776838B1 (en) | 1987-10-28 | 2010-08-17 | Wellstat Therapeutics Corporation | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| US5470838A (en) * | 1987-10-28 | 1995-11-28 | Pro-Neuron, Inc. | Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine |
| US5736531A (en) | 1987-10-28 | 1998-04-07 | Pro-Neuron, Inc. | Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
| US7173017B1 (en) * | 1987-10-28 | 2007-02-06 | Wellstat Therapeutics Corporation | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| JP4408450B2 (ja) * | 1994-07-01 | 2010-02-03 | ウェルスタット セラピューティクス コーポレイション | 全身性炎症および炎症性肝炎の処置のためのピリミジンヌクレオチド前駆体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2556907A (en) * | 1950-01-27 | 1951-06-12 | Du Pont | Resolution of lysine |
| US2738299A (en) * | 1953-05-11 | 1956-03-13 | Abbott Lab | Stable nutritive amino acid compositions |
| US2802864A (en) * | 1953-09-01 | 1957-08-13 | Int Minerals & Chem Corp | Higher alkyl amine salts of glutamic acid |
| US2992163A (en) * | 1955-11-07 | 1961-07-11 | Lilly Co Eli | Use of 4-chloro-1, 2-pyrazole for controlling epileptic seizures |
| US2859244A (en) * | 1956-09-28 | 1958-11-04 | Dow Chemical Co | Resolution of dl-lysine with d-camphoric acid |
| US3020278A (en) * | 1959-09-16 | 1962-02-06 | Jr Edgar A Ferguson | Vitamin-orotic acid compositions |
| US3062722A (en) * | 1960-03-15 | 1962-11-06 | Garofalo Domenico | Therapeutic 2-aminoethanethiol orate |
-
1960
- 1960-07-29 FR FR834523A patent/FR88M/fr active Active
-
1961
- 1961-07-25 GB GB26856/61A patent/GB922361A/en not_active Expired
- 1961-07-27 CH CH884561A patent/CH394216A/fr unknown
- 1961-07-27 US US127154A patent/US3161565A/en not_active Expired - Lifetime
- 1961-07-27 BE BE606638A patent/BE606638A/fr unknown
- 1961-07-28 ES ES0269442A patent/ES269442A1/es not_active Expired
- 1961-07-28 DK DK312061AA patent/DK105811C/da active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037488A2 (de) * | 1980-03-25 | 1981-10-14 | Hrvoje Dr. Krnjevic | Pharmazeutisches Mittel zur Heilung von entzündlichen und/oder degenerativen und/oder atrophischen Schleimhauterkrankungen |
| EP0037488A3 (en) * | 1980-03-25 | 1982-11-24 | Hrvoje Dr. Krnjevic | Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes |
Also Published As
| Publication number | Publication date |
|---|---|
| BE606638A (fr) | 1961-11-16 |
| DK105811C (da) | 1966-11-14 |
| CH394216A (fr) | 1965-06-30 |
| GB922361A (en) | 1963-03-27 |
| US3161565A (en) | 1964-12-15 |
| ES269442A1 (es) | 1962-01-01 |